-
EP2167101
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2167101
| EP2167101 - ANTIBODIES AND SIRNA AGAINST GROWTH HORMONE, PROLACTIN AND PROLIFERIN FOR USE IN THE TREATMENT OF TUMORS AND ENDOMETRIOSIS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.04.2011 Database last updated on 31.08.2024 | Most recent event Tooltip | 22.04.2011 | Application deemed to be withdrawn | published on 25.05.2011 [2011/21] | Applicant(s) | For all designated states Auckland Uniservices Limited 70 Symonds Street Auckland / NZ | [2010/13] | Inventor(s) | 01 /
LOBIE, Peter 593a Riddell Road Glendowie Auckland / NZ | [2010/13] | Representative(s) | Finnie, Isobel Lara, et al Mintz Levin Cohn Ferris Glovsky and Popeo Intellectual Property LLP Alder Castle 10 Noble Street, London EC2V 7JX / GB | [N/P] |
| Former [2010/13] | Finnie, Isobel Lara, et al Mintz Levin Cohn Ferris Glovsky and Popeo Intellectual Property LLP Adler Castle 10 Noble Street London EC2V 7JX / GB | Application number, filing date | 08826535.0 | 30.05.2008 | [2010/13] | WO2008IB02585 | Priority number, date | US20070940939P | 30.05.2007 Original published format: US 940939 P | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009013621 | Date: | 29.01.2009 | Language: | EN | [2009/05] | Type: | A2 Application without search report | No.: | EP2167101 | Date: | 31.03.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.01.2009 takes the place of the publication of the European patent application. | [2010/13] | Search report(s) | International search report - published on: | EP | 25.02.2010 | Classification | IPC: | A61K31/713, A61K39/395, C07K16/18, C07K16/26, C12N15/11, G01N33/50 | [2010/13] | CPC: |
A61K31/713 (EP,US);
A61P15/08 (EP);
A61P35/00 (EP);
C07K16/26 (EP,US);
C12N15/1136 (EP,US);
G01N33/57407 (EP,US);
C07K2317/11 (EP,US);
C07K2317/23 (EP,US);
C07K2317/73 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/13] | Title | German: | ANTIKÖRPER UND SIRNA GEGEN WACHSTUMSHORMONE, PROLACTIN UND PROLIFERIN ZUR VERWENDUNG BEI DER BEHANDLUNG VON TUMOREN UND ENDOMETRIOSE | [2010/13] | English: | ANTIBODIES AND SIRNA AGAINST GROWTH HORMONE, PROLACTIN AND PROLIFERIN FOR USE IN THE TREATMENT OF TUMORS AND ENDOMETRIOSIS | [2010/13] | French: | INHIBITEURS DE L'HORMONE DE CROISSANCE ET DES HORMONES AFFÉRENTES, ET PROCÉDÉS D'UTILISATION DE CEUX-CI | [2010/13] | Entry into regional phase | 30.12.2009 | National basic fee paid | 30.12.2009 | Designation fee(s) paid | 30.12.2009 | Examination fee paid | Examination procedure | 30.12.2009 | Amendment by applicant (claims and/or description) | 30.12.2009 | Examination requested [2010/13] | 27.07.2010 | Despatch of a communication from the examining division (Time limit: M04) | 07.12.2010 | Application deemed to be withdrawn, date of legal effect [2011/21] | 11.01.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/21] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.07.2010 | Fees paid | Renewal fee | 25.05.2010 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XP]US2007243192 (WICHA MAX S [US], et al) [XP] 1-3,8,12-17,19-20,22,24,28 * paragraphs 5, 22 paragraphs 6-8, 52 examples 1, 3 paragraphs 9, 70 *; | [X] - SINHA Y N ET AL, "Inhibition of mammary tumors by growth hormone and prolactin antisera", CLINICAL RESEARCH, THOROFARE, NJ, US, (19740101), vol. 22, no. 2, ISSN 0009-9279, page 130A, XP009126598 [X] 1-3,5,8,12-17,20,22,24,28 * the whole document * | [X] - MERSHON JOHN ET AL, "Prolactin is a local growth factor in rat mammary tumors", ENDOCRINOLOGY, BALTIMORE, MD, US, (19950101), vol. 136, no. 8, ISSN 0013-7227, pages 3619 - 3623, XP009126599 [X] 1-2,5,8,10,12-13,15-17,25,28,33-35 * abstract * DOI: http://dx.doi.org/10.1210/en.136.8.3619 | [AP] - PAN ET AL, "Inhibition of cell proliferation by siRNA targeting hPRLR in breast cancer MCF-7 cell line", 20071101, (20071101), vol. 21, no. 6, pages 372 - 376, XP022383939 [AP] 1-37 * abstract table 1 figure 2 * | [A] - SISSOM-DEMORE J ET AL, "A monoclonal antibody to prolactin receptor inhibits proliferation of breast cancer cells", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, (19960606), vol. 10, no. 6, ISSN 0892-6638, page A1389, XP008113243 [A] 1-37 * abstract * | [A] - "Inhibition of cell proliferation by antibodies to prolactin - D.P. Hartmann. Georgetown Univ. Sch. Med., Washington, D.C. 20007", CYTOKINE, ACADEMIC PRESS LTD, PHILADELPHIA, PA, US, vol. 1, no. 1, ISSN 1043-4666, (19891101), page 91, (19891101), XP022967758 [A] 1-37 * abstract * DOI: http://dx.doi.org/10.1016/1043-4666(89)91163-0 | [X] - BUTLER T P ET AL, "REGRESSION OF PROLACTIN DEPENDENT RAT MAMMARY CARCINOMA IN RESPONSE TO ANTI HORMONE TREATMENT", CANCER RESEARCH, (1971), vol. 31, no. 6, ISSN 0008-5472, pages 817 - 820, XP002559356 [X] 1-2,5,8,10,12-13,15-17,25,28 * abstract charts 1, 2 table 1 * | [X] - TOFT D J ET AL, "Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 20011106 US, (20011106), vol. 98, no. 23, ISSN 0027-8424, pages 13055 - 13059, XP002559357 [X] 25,28,33-34 * abstract fig. 1, 4, 5 * DOI: http://dx.doi.org/10.1073/pnas.231364798 | [A] - TWOROGER S S ET AL, "Prolactin and breast cancer risk", CANCER LETTERS, NEW YORK, NY, US, vol. 243, no. 2, ISSN 0304-3835, (20061118), pages 160 - 169, (20061118), XP025021674 [A] 1-37 DOI: http://dx.doi.org/10.1016/j.canlet.2006.01.032 | [A] - BENGTSON N W ET AL, "Inhibition of tumor growth by the antiangiogenic placental hormone, proliferin-related protein", MOLECULAR ENDOCRINOLOGY 2000 US, (2000), vol. 14, no. 12, ISSN 0888-8809, pages 1934 - 1943, XP002559358 [A] 1-37 DOI: http://dx.doi.org/10.1210/me.14.12.1934 |